Who Owns Attovia Therapeutics Stock?
NASDAQ: ATTOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:56 PM ET
Ownership breakdown
- Held by institutions
- 36.45%
- Held by insiders
- 8.85%
- Institutional holders
- 12
- Institutions 36.5%
- Insiders 8.9%
- Public and other 54.7%
Who owns Attovia Therapeutics stock?
Institutional investors own about 36.5% of Attovia Therapeutics's shares, spread across 12 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 8.85% of ATTO.
Summary generated from market data by MetaCap's automated system. Methodology
Top mutual fund and ETF holders of ATTO
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 35.00K | 0.08% |
Frequently asked questions
What percentage of Attovia Therapeutics is owned by institutions?
Institutions own about 36.5% of ATTO shares and 40.0% of the public float.
How much of Attovia Therapeutics do insiders own?
Insiders, such as officers and directors, own about 8.85% of ATTO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.